This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Oct 2010

Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference

Barry D. Quart, PharmD, president and chief executive officer, will present at the Oppenheimer 21st Annual Healthcare Conference in New York.

SAN DIEGO, Oct. 27 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the Oppenheimer 21st Annual Healthcare Conference in New York, NY. Dr. Quart is scheduled to present at 10:50 a.m. EDT on Tuesday, November 2, 2010.

This presentation will be webcast and can be accessed on the Investor Relations section of Ardea's website at www.ardeabio.com. Please connect to Ardea's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical

Related News